SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
10-Q	Quarterly report which provides a continuing view of a company's financial position	May 13, 2010	View HTML 0001193125-10-118801.pdf 0001193125-10-118801.rtf 0001193125-10-118801.xls
CT ORDER	CT ORDER	May 13, 2010	View HTML 9999999997-10-011403.pdf 9999999997-10-011403.rtf
8-K	Report of unscheduled material events or corporate event	May 12, 2010	View HTML 0001193125-10-117474.pdf 0001193125-10-117474.rtf 0001193125-10-117474.xls
8-K	Report of unscheduled material events or corporate event	Apr 26, 2010	View HTML 0001193125-10-093394.pdf 0001193125-10-093394.rtf 0001193125-10-093394.xls
SC 13G	A statement of beneficial ownership of common stock by certain persons	Apr 09, 2010	View HTML 0001144204-10-019348.pdf 0001144204-10-019348.rtf 0001144204-10-019348.xls
10-Q	Quarterly report which provides a continuing view of a company's financial position	Feb 12, 2010	View HTML 0001193125-10-030558.pdf 0001193125-10-030558.rtf 0001193125-10-030558.xls
8-K	Report of unscheduled material events or corporate event	Feb 11, 2010	View HTML 0001193125-10-028697.pdf 0001193125-10-028697.rtf 0001193125-10-028697.xls
EFFECT	EFFECT	Jan 07, 2010	View HTML 9999999995-10-000137.pdf 9999999995-10-000137.rtf
EFFECT	EFFECT	Jan 07, 2010	View HTML 9999999995-10-000138.pdf 9999999995-10-000138.rtf
UPLOAD	UPLOAD	Jan 07, 2010	View HTML 0000000000-10-001051.pdf

Data provided by Kaleidoscope.